G. Rozic

A multifunctional 5-aminolevulinic acid derivative induces erythroid differentiation of K562 human erythroleukemic cells.

Z. Malik, A. Nudelman, A. Rephaeli, 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Newly diagnosed multiple myeloma patients carrying monoallelic deletion of the whole locus of immunoglobulin heavy chain gene have a better prognosis compared to those with t(4;14) and t(14;16)

A. Nagler, L. Trakhtenbrot, N. Amariglio, 2019, Genes, chromosomes & cancer.

Translocation t(11;14) in newly diagnosed patients with multiple myeloma: Is it always favorable?

A. Nagler, L. Trakhtenbrot, N. Amariglio, 2016, Genes, chromosomes & cancer.

Bi-functional prodrugs of 5-aminolevulinic acid and butyric acid increase erythropoiesis in anemic mice in an erythropoietin-independent manner.

Z. Malik, A. Nudelman, A. Rephaeli, 2016, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Effects of histone deacetylase inhibitory prodrugs on epigenetic changes and DNA damage response in tumor and heart of glioblastoma xenograft

A. Nudelman, S. Cutts, A. Rephaeli, 2017, Investigational New Drugs.

Dynamic Changes in Neurexins' Alternative Splicing: Role of Rho-Associated Protein Kinases and Relevance to Memory Formation

N. Zisapel, G. Rozic, Y. Piontkewitz, 2011, PloS one.

STK405759 as a combination therapy with bortezomib or dexamethasone, in in vitro and in vivo multiple myeloma models

A. Nagler, M. Leiba, G. Rozic, 2018, Oncotarget.

The novel compound STK 405759 is a microtubule-targeting agent with potent and selective cytotoxicity against multiple myeloma in vitro and in vivo

A. Nagler, D. Ben-Shushan, J. Jakubikova, 2017 .

The novel compound STK405759 is a microtubule-targeting agent with potent and selective cytotoxicity against multiple myeloma in vitro and in vivo

A. Nagler, D. Ben-Shushan, J. Jakubikova, 2016, Oncotarget.

Thrombin generation as a predictor of thromboembolic events in multiple myeloma patients.

A. Nagler, M. Leiba, G. Rozic, 2017, Blood cells, molecules & diseases.

Exonal Elements and Factors Involved in the Depolarization-Induced Alternative Splicing of Neurexin 2

N. Zisapel, G. Rozic, Z. Lupowitz, 2012, Journal of Molecular Neuroscience.